Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

Prostate Cancer Survival Is Rising, but Mental Health Struggles Persist After Treatment

by Team Lumida
December 12, 2025
in Health and Longevity
Reading Time: 3 mins read
A A
0
Prostate Cancer Survival Is Rising, but Mental Health Struggles Persist After Treatment
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways
Powered by lumidawealth.com

  • Prostate cancer survival rates now exceed 95% at 15 years, shifting focus toward long-term quality of life and mental health.
  • Treatment side effects such as erectile dysfunction, incontinence, and fatigue often affect self-esteem, masculinity, and body image.
  • Men with rigid views of masculinity tend to struggle more with emotional adjustment after treatment.
  • Support groups, open communication, exercise, and reframing masculinity can significantly improve psychological well-being.

What Happened?

Advances in prostate cancer treatment have dramatically improved survival, with nearly all diagnosed men now living at least 10 years and most surpassing 15 years. As outcomes improve, attention has increasingly turned to the mental and emotional challenges survivors face after treatment. Many men experience lasting side effects—including sexual dysfunction, physical weakness, and hormonal changes—that can take a psychological toll. Patients often report feeling unprepared for these changes, noting that treatment decisions sometimes happen without sufficient discussion of long-term side effects and quality-of-life tradeoffs.


Why It Matters?

Long-term survivorship has revealed that prostate cancer is not just a medical condition but a deeply personal and psychological one. Changes to sexual function and physical independence can challenge identity, particularly for men who strongly associate masculinity with sexual performance or physical strength. These struggles can lead to anxiety, depression, and anger if left unaddressed. However, evidence suggests that mental health outcomes improve when men receive better pre-treatment counseling, involve partners in decision-making, and access peer support. Redefining masculinity and intimacy—rather than clinging to pre-illness ideals—plays a critical role in emotional recovery.


What’s Next?

Experts emphasize the need for more comprehensive conversations before treatment begins, helping men align medical choices with personal values and long-term expectations. Support groups and mentoring programs are likely to play a growing role in survivorship care, offering reassurance and practical coping strategies. Regular exercise is increasingly recommended as part of treatment and recovery, given its proven mental health benefits even in advanced cases. As survival continues to improve, integrating mental health support into standard prostate cancer care will be essential to ensuring not just longer lives, but better ones.

Source
Previous Post

Disney Goes All-In on OpenAI, Turning Iconic IP Into an AI Video Platform

Next Post

Broadcom Shares Slide as AI Backlog Fails to Clear a Higher Bar

Recommended For You

Wearable Health Devices: Helpful or Harmful to Our Well-Being?

by Team Lumida
1 day ago
Wearable Health Devices: Helpful or Harmful to Our Well-Being?

Key Takeaways: Powered by lumidawealth.com Wearable devices like the Oura Ring and Apple Watch have become essential tools for tracking health metrics such as sleep and heart rate. While...

Read more

Coffee and Longevity: Evidence Builds for a Simple, Scalable Health Lever

by Team Lumida
5 days ago
coffee bean lot

Key Takeaways Powered by lumidawealth.com Moderate coffee intake (3–5 cups daily) is consistently linked to longer lifespan and lower chronic disease risk. Research suggests coffee may slow biological aging...

Read more

Trump Pushes Back on Health Scrutiny as Age-Related Concerns Enter the Political Spotlight

by Team Lumida
1 week ago
Wall Street Questions Whether Stablecoins Can Really Fuel $3 Trillion Treasury Demand

Key Takeaways Powered by lumidawealth.com Health optics are becoming a political variable: Trump disputes concerns but the reporting highlights visible aging cues and lifestyle choices that fuel scrutiny. Governance...

Read more

Gabapentin’s Rise as an Opioid Alternative Comes With Growing Safety Concerns

by Team Lumida
2 weeks ago
Gabapentin’s Rise as an Opioid Alternative Comes With Growing Safety Concerns

Key Takeaways Powered by lumidawealth.com Gabapentin has become one of the most widely prescribed drugs in the U.S., largely replacing opioids despite limited evidence for many uses. Growing research...

Read more

Your Brain Ages in Five Stages—New Research Maps Key Turning Points Across the Lifespan

by Team Lumida
2 weeks ago
blue and green peacock feather

Key Takeaways Powered by lumidawealth.com Brain development and aging follow five distinct stages, with major shifts around ages 9, 32, 66, and 83. Brain “adolescence” lasts far longer than...

Read more

America’s Seniors Are Taking Too Many Medications — and Paying the Price

by Team Lumida
3 weeks ago
America’s Seniors Are Taking Too Many Medications — and Paying the Price

Key TakeawaysPowered by lumidawealth.com One in six Medicare seniors were prescribed eight or more medications at the same time. Millions of seniors are taking drugs that geriatric experts warn...

Read more

LA Wildfires Triggered a Surge in ER Visits—A Warning Signal for Health-Cost Inflation in Climate Events

by Team Lumida
3 weeks ago
LA Wildfires Triggered a Surge in ER Visits—A Warning Signal for Health-Cost Inflation in Climate Events

Key takeawaysPowered by lumidawealth.com A new Cedars-Sinai emergency-department analysis found post-wildfire health impacts were broader than expected, including a sharp rise in “unexplained” symptoms. ER visits for mysterious symptoms...

Read more

How Caregivers Can Protect Their Well-Being When They’re Overwhelmed

by Team Lumida
1 month ago
four person hands wrap around shoulders while looking at sunset

Key Takeaways Powered by lumidawealth.com Caregiving—especially for aging or dying loved ones—creates sustained emotional, physical, and logistical strain. Mental strategies such as journaling, mindfulness, reframing, and honest emotional expression...

Read more

How to Protect Your Well-Being While Supporting Others

by Team Lumida
1 month ago
How to Protect Your Well-Being While Supporting Others

Key Takeaways:Powered by lumidawealth.com• Long-term caregiving often brings exhaustion, grief, and emotional strain—especially during the holidays.• Mental habits—journaling, gratitude, humor, meditation—proved more effective than routines alone.• Healthy coping requires...

Read more

Weight-Loss Blockbusters Stumble in Alzheimer’s: Semaglutide Shows No Cognitive Benefit

by Team Lumida
2 months ago
Weight-Loss Blockbusters Stumble in Alzheimer’s: Semaglutide Shows No Cognitive Benefit

Key Takeaways Novo Nordisk reported that daily oral semaglutide did not slow cognitive decline versus placebo in more than 3,800 people with early Alzheimer’s disease over two years....

Read more
Next Post
Broadcom Shares Slide as AI Backlog Fails to Clear a Higher Bar

Broadcom Shares Slide as AI Backlog Fails to Clear a Higher Bar

Coinbase Prepares Push Into Prediction Markets and Tokenized Stocks

Coinbase Prepares Push Into Prediction Markets and Tokenized Stocks

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Premium Chinese Brands: Why Investors Are Losing Faith

Can China Build Its Own Factory Robots to Meet Demand?

September 3, 2024
China’s Bold Economic Moves: What You Need to Know Now

China’s Rare-Earth Magnet Exports Plunge 74% in May Amid Trade Tensions with U.S.

June 20, 2025
a group of cars parked on the side of a road

Falling Mortgage Rates: Why Homebuyers Still Struggle

August 15, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018